All PlansAdministrativeLow impact
Voluntary nationwide recall: Atorvastatin (Alkem – October)
UPMC Health Plan·Family Medicine, Internal Medicine, Cardiology +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
UPMC Health Plan has issued a voluntary recall notice for Atorvastatin Calcium Tablets from Ascend Laboratories due to improper dissolution rates that may reduce effectiveness. Healthcare practices should be aware that patients may need medication changes or alternative prescriptions.
Action Required
Immediately: Clinical staff should be aware of the Atorvastatin recall when patients call with medication concerns. Refer patients to their pharmacy or the FDA website to check if their medication is affected. No billing changes are required, but documentation of medication changes in patient records may be needed for continuity of care.